期刊文献+

肾病综合征患者他克莫司血药浓度影响因素分析 被引量:19

Analysis of influence factors on tacrolimus concentration in patients with nephrotic syndrome
原文传递
导出
摘要 目的分析他克莫司血药浓度监测结果,探讨他克莫司血药浓度影响因素。方法回顾性收集2015年8月至2016年7月于我院用他克莫司治疗的肾病综合征患者114例,记录用药情况,分析年龄、性别、肝肾功指标、合并用药等与他克莫司血药浓度的相关性。结果血药浓度在有效范围内的患者占48.25%;女性给药剂量显著高于男性(P<0.05),而标准化血药浓度显著低于男性(P<0.05);不同浓度组间合用五酯片比例差异有统计学意义(P<0.05)。结论性别及合用五酯片能够显著影响他克莫司血药浓度。临床医师和药师应遵循个体化用药原则,根据血药浓度的影响因素制定和调整他克莫司用药方案。 Objective To investigate influence factors of tacrolimus blood concentration,and provide reference for the clinical use of tacrolimus by analyzing tacrolimus blood concentrationin patients with nephrotic syndrome. Methods Data of tacrolimus usage were retrospectively collected from August 2015 to July 2016 in 114 patients with nephrotic syndrome in our hospital. Association of dose,age,sex,drug combination,blood routine index,hepatic and kidney function index with tacrolimus blood concentrations were analyzed. Results Tacrolimus concentration in the effective range of patients was 48. 25%. Dose of female group was significantly higher than that in male group( P〈0. 05),while dose-adjusted concentration of female group was significantly lower than that of male group( P〈0. 05). There was significant difference in the proportion of combined Wuzhi tablet among different concentration groups( P〈0. 05). Conclusion Sex and combination with Wuzhi tablet could significantly affect tacrolimus concentration. Physicians and clinical pharmacists should follow the principle of individualized medicine,formulate and adjust drug regimen according to the influence factors of tacrolimus concentration.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2017年第18期1810-1812,1816,共4页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金资助项目(81673510) 辽宁省教育厅科学研究基金资助项目(LK201611)
关键词 他克莫司 血药浓度 影响因素 肾病综合征 tacrolimus blood concentration influence factor nephrotic syndrome
  • 相关文献

参考文献5

二级参考文献82

共引文献38

同被引文献136

引证文献19

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部